These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32369230)

  • 1. Overexpression of long noncoding RNA HOXA-AS2 predicts an adverse prognosis and promotes tumorigenesis via SOX4/PI3K/AKT pathway in acute myeloid leukemia.
    Qu Y; Wang Y; Wang P; Lin N; Yan X; Li Y
    Cell Biol Int; 2020 Aug; 44(8):1745-1759. PubMed ID: 32369230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
    Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
    Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA HOXA-AS2 functions as an oncogene by binding to EZH2 and suppressing LATS2 in acute myeloid leukemia (AML).
    Feng Y; Hu S; Li L; Peng X; Chen F
    Cell Death Dis; 2020 Dec; 11(12):1025. PubMed ID: 33268767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA HOXA-AS2 Promotes Oral Squamous Cell Proliferation, Migration, and Invasion via Upregulating EZH2 as an Oncogene.
    Zhao Z; Xing Y; Yang F; Zhao Z; Shen Y; Song J; Jing S
    Technol Cancer Res Treat; 2021; 20():15330338211039109. PubMed ID: 34519570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.
    Xie M; Sun M; Zhu YN; Xia R; Liu YW; Ding J; Ma HW; He XZ; Zhang ZH; Liu ZJ; Liu XH; De W
    Oncotarget; 2015 Oct; 6(32):33587-601. PubMed ID: 26384350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway.
    Elsayed AM; Bayraktar E; Amero P; Salama SA; Abdelaziz AH; Ismail RS; Zhang X; Ivan C; Sood AK; Lopez-Berestein G; Rodriguez-Aguayo C
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARID1B/SUB1-activated lncRNA HOXA-AS2 drives the malignant behaviour of hepatoblastoma through regulation of HOXA3.
    Liu G; Liu B; Liu X; Xie L; He J; Zhang J; Dong R; Ma D; Dong K; Ye M
    J Cell Mol Med; 2021 Apr; 25(7):3524-3536. PubMed ID: 33683826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer.
    Ding J; Xie M; Lian Y; Zhu Y; Peng P; Wang J; Wang L; Wang K
    Oncogenesis; 2017 Jan; 6(1):e288. PubMed ID: 28112720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
    Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
    Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway.
    Zhao Q; Zhao S; Li J; Zhang H; Qian C; Wang H; Liu J; Zhao Y
    Biomed Pharmacother; 2019 Jan; 109():1640-1649. PubMed ID: 30551418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
    Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
    Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway.
    Ma L; Kuai WX; Sun XZ; Lu XC; Yuan YF
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7867-7876. PubMed ID: 30536332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset.
    Huang R; Liao X; Wang X; Li Q
    J Cancer; 2021; 12(7):2151-2164. PubMed ID: 33754013
    [No Abstract]   [Full Text] [Related]  

  • 15. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
    Xiao S; Song B
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma.
    Zhang P; Cao P; Zhu X; Pan M; Zhong K; He R; Li Y; Jiao X; Gao Y
    Oncotarget; 2017 May; 8(20):33137-33143. PubMed ID: 28388535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells.
    Yang Y; Dai W; Sun Y; Zhao Z
    Oncol Rep; 2019 Apr; 41(4):2311-2320. PubMed ID: 30720129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer.
    Wang J; Su Z; Lu S; Fu W; Liu Z; Jiang X; Tai S
    Clin Chim Acta; 2018 Oct; 485():229-233. PubMed ID: 29981289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis.
    Jiang L; Wu Z; Meng X; Chu X; Huang H; Xu C
    Hum Gene Ther; 2019 May; 30(5):618-631. PubMed ID: 30375256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Non-Coding RNA HOXA-AS2 Enhances The Malignant Biological Behaviors In Glioma By Epigenetically Regulating RND3 Expression.
    Wu L; Zhu X; Song Z; Chen D; Guo M; Liang J; Ding D; Wang W; Yan D
    Onco Targets Ther; 2019; 12():9407-9419. PubMed ID: 31819475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.